The duloxetine active pharmaceutical ingredients market is growing as demand rises for medicines used in treatment pathways for depression, anxiety, fibromyalgia, neuropathic pain, and chronic musculoskeletal pain. The market was valued at USD 1.54 billion in 2024 and is projected to reach USD 1.73 billion by 2032, growing at a CAGR of 1.48%.
The Duloxetine Active...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek